{"hands_on_practices": [{"introduction": "Before an assay can be used for quantitative measurement, we must first establish its lower limits of performance. The Limit of Blank (LOB) and Limit of Detection (LOD) are key metrics that define an assay's analytical sensitivity, determining the lowest concentration of an analyte that can be reliably distinguished from an absence of analyte. This exercise [@problem_id:4989947] provides hands-on practice in calculating these fundamental limits from summary statistics, grounding the abstract concepts of false positives and false negatives in a concrete statistical framework.", "problem": "A translational biomarker assay for a low-abundance plasma protein is being analytically validated following Clinical and Laboratory Standards Institute (CLSI) guidance. The assayâ€™s readout is calibrated to concentration in nanograms per milliliter (ng/mL). Replicate runs under stable conditions yielded the following summary statistics: the blank (no analyte) readings have sample mean $0.05$ and sample standard deviation $0.02$, and low-concentration replicates at a trace level near the lower range exhibit a sample standard deviation $0.03$. Assume measurement errors are independent and identically distributed and well-approximated by Gaussian noise for both blank and low-level conditions.\n\nBy definition, the Limit of Blank (LOB) is the highest apparent analyte concentration expected to be observed when measuring replicates of a blank sample, under a chosen one-sided false positive probability criterion. Under the Gaussian model, LOB is the one-sided $0.95$ quantile of the blank measurement distribution. The Limit of Detection (LOD) is defined as the smallest true analyte concentration such that, when measured under the low-level noise model, the probability that the observed measurement exceeds the LOB is $0.95$.\n\nUse the one-sided $0.95$ quantile of the standard normal distribution equal to $1.645$. Starting from these definitions and the Gaussian assumption, derive explicit expressions for LOB and LOD in terms of $\\mu_{\\text{blank}}$, $\\sigma_{\\text{blank}}$, and $\\sigma_{\\text{low}}$, and then compute their numerical values using $\\mu_{\\text{blank}}=0.05$, $\\sigma_{\\text{blank}}=0.02$, and $\\sigma_{\\text{low}}=0.03$. Round your final numerical answers to four significant figures and express them in ng/mL. Provide your final answer as a two-entry row matrix where the first entry is LOB and the second entry is LOD.", "solution": "The problem is subjected to validation and is determined to be valid. It is scientifically grounded in the principles of analytical chemistry and statistics, well-posed with sufficient information for a unique solution, and objectively stated.\n\nThe problem asks for the derivation and calculation of two key analytical performance metrics for a biomarker assay: the Limit of Blank (LOB) and the Limit of Detection (LOD). The analysis is based on a Gaussian noise model for the assay measurements.\n\nLet $X_{\\text{blank}}$ be the random variable representing the measured concentration of a blank sample (containing no analyte). The problem states that the measurement error is Gaussian. Therefore, the distribution of $X_{\\text{blank}}$ is a normal distribution with mean $\\mu_{\\text{blank}}$ and standard deviation $\\sigma_{\\text{blank}}$.\n$$X_{\\text{blank}} \\sim \\mathcal{N}(\\mu_{\\text{blank}}, \\sigma_{\\text{blank}}^2)$$\nThe given sample statistics are used as estimates for these population parameters: $\\mu_{\\text{blank}} = 0.05$ and $\\sigma_{\\text{blank}} = 0.02$.\n\nFirst, we derive the expression for the Limit of Blank (LOB). The LOB is defined as the $0.95$ quantile of the blank measurement distribution. This is the value LOB such that the probability of a blank measurement being less than or equal to it is $0.95$.\n$$P(X_{\\text{blank}} \\le \\text{LOB}) = 0.95$$\nTo find this value, we standardize the random variable $X_{\\text{blank}}$ to a standard normal variable $Z \\sim \\mathcal{N}(0, 1)$:\n$$Z = \\frac{X_{\\text{blank}} - \\mu_{\\text{blank}}}{\\sigma_{\\text{blank}}}$$\nThe probability statement becomes:\n$$P\\left(\\frac{X_{\\text{blank}} - \\mu_{\\text{blank}}}{\\sigma_{\\text{blank}}} \\le \\frac{\\text{LOB} - \\mu_{\\text{blank}}}{\\sigma_{\\text{blank}}}\\right) = 0.95$$\nLet $z_{0.95}$ denote the $0.95$ quantile of the standard normal distribution, which is given as $1.645$. The equation implies:\n$$\\frac{\\text{LOB} - \\mu_{\\text{blank}}}{\\sigma_{\\text{blank}}} = z_{0.95}$$\nSolving for LOB, we obtain the explicit expression in terms of the blank sample parameters:\n$$\\text{LOB} = \\mu_{\\text{blank}} + z_{0.95} \\sigma_{\\text{blank}}$$\nSubstituting the given value $z_{0.95} = 1.645$, the expression is:\n$$\\text{LOB} = \\mu_{\\text{blank}} + 1.645 \\sigma_{\\text{blank}}$$\nNow, we compute the numerical value of LOB using the provided data: $\\mu_{\\text{blank}} = 0.05$ ng/mL and $\\sigma_{\\text{blank}} = 0.02$ ng/mL.\n$$\\text{LOB} = 0.05 + 1.645 \\times 0.02 = 0.05 + 0.0329 = 0.0829$$\nThe problem requires rounding to four significant figures. Thus, $\\text{LOB} = 0.08290$ ng/mL.\n\nNext, we derive the expression for the Limit of Detection (LOD). The LOD is the smallest true analyte concentration such that a measurement has a $0.95$ probability of exceeding the LOB. Let $X_{\\text{LOD}}$ be the random variable for a measurement of a sample with this true concentration, LOD. The measurement noise is modeled by the \"low-level noise model\", with standard deviation $\\sigma_{\\text{low}}$. Assuming the assay is unbiased, the mean of the measurement distribution is the true concentration, LOD.\n$$X_{\\text{LOD}} \\sim \\mathcal{N}(\\text{LOD}, \\sigma_{\\text{low}}^2)$$\nThe condition for LOD is:\n$$P(X_{\\text{LOD}}  \\text{LOB}) = 0.95$$\nThis corresponds to a Type II error (false negative) rate of $\\beta = 1 - 0.95 = 0.05$. We standardize the variable $X_{\\text{LOD}}$:\n$$P\\left(\\frac{X_{\\text{LOD}} - \\text{LOD}}{\\sigma_{\\text{low}}}  \\frac{\\text{LOB} - \\text{LOD}}{\\sigma_{\\text{low}}}\\right) = 0.95$$\nLet $Z$ be a standard normal variable. The inequality is $P(Z  q) = 0.95$, which implies that $q$ is the $0.05$ quantile of the standard normal distribution, $z_{0.05}$. By the symmetry of the normal distribution, $z_{0.05} = -z_{0.95} = -1.645$.\nTherefore, we have:\n$$\\frac{\\text{LOB} - \\text{LOD}}{\\sigma_{\\text{low}}} = -z_{0.95}$$\nSolving for LOD, we get the expression:\n$$\\text{LOD} = \\text{LOB} + z_{0.95} \\sigma_{\\text{low}}$$\nSubstituting the expression for LOB, we obtain the explicit expression for LOD in terms of all three given parameters: $\\mu_{\\text{blank}}$, $\\sigma_{\\text{blank}}$, and $\\sigma_{\\text{low}}$.\n$$\\text{LOD} = (\\mu_{\\text{blank}} + z_{0.95} \\sigma_{\\text{blank}}) + z_{0.95} \\sigma_{\\text{low}} = \\mu_{\\text{blank}} + z_{0.95} (\\sigma_{\\text{blank}} + \\sigma_{\\text{low}})$$\nWith $z_{0.95} = 1.645$, the expression is:\n$$\\text{LOD} = \\mu_{\\text{blank}} + 1.645(\\sigma_{\\text{blank}} + \\sigma_{\\text{low}})$$\nNow, we compute the numerical value of LOD. We use the previously calculated value of LOB and the given value $\\sigma_{\\text{low}} = 0.03$ ng/mL.\n$$\\text{LOD} = \\text{LOB} + 1.645 \\sigma_{\\text{low}} = 0.0829 + 1.645 \\times 0.03$$\n$$\\text{LOD} = 0.0829 + 0.04935 = 0.13225$$\nRounding this result to four significant figures gives $\\text{LOD} = 0.1323$ ng/mL.\n\nThe final numerical values are $\\text{LOB} = 0.08290$ ng/mL and $\\text{LOD} = 0.1323$ ng/mL.", "answer": "$$\\boxed{\\begin{pmatrix} 0.08290  0.1323 \\end{pmatrix}}$$", "id": "4989947"}, {"introduction": "An ideal biomarker assay would be perfectly specific, generating a signal only from the target analyte. In practice, antibodies may exhibit cross-reactivity with other molecules, a phenomenon that can introduce significant bias, and analytical specificity is the measure of an assay's ability to remain unaffected by such interfering substances. This problem [@problem_id:4989933] guides you through a first-principles derivation to quantify the impact of a competing interferent, demonstrating how the interplay between binding affinities and concentrations determines the degree of signal distortion.", "problem": "A single-site capture antibody used in an Enzyme-Linked Immunosorbent Assay (ELISA) is being analytically validated for specificity against a known interfering compound. The capture antibody can bind either the true analyte, denoted by $A$, or the interferent, denoted by $I$, at the same site. The detection system does not distinguish between $A$-bound and $I$-bound states, so any occupied capture site yields signal. The binding reactions are $R + A \\rightleftharpoons RA$ and $R + I \\rightleftharpoons RI$, where $R$ is the free capture antibody, and the association constants are $K_{a,A}$ and $K_{a,I}$, respectively. The affinity ratio is defined as $r = \\frac{K_{a,I}}{K_{a,A}}$, and is given to be $r = 0.1$. In a validation sample, the interferent concentration is set to $[I] = 10 \\times [A]$, where $[A]$ is the analyte concentration.\n\nAssume thermodynamic equilibrium and mass action apply for a single binding site that can bind either $A$ or $I$ without cooperativity, and that the macroscopic signal $S$ is proportional to the fraction of capture sites occupied (regardless of whether occupancy is by $A$ or $I$). Define the \"percent cross-reactivity\" as the ratio of the signal contributed by $I$ to the signal contributed by $A$ under the same $[A]$ and $[I]$ conditions, expressed as a decimal fraction (i.e., a number between $0$ and $1$ without a percent sign). Derive from first principles an expression for this ratio under the stated assumptions and compute its value for $r = 0.1$ and $[I] = 10 \\times [A]$. Round your final numeric answer to four significant figures. No units are required for the final reported quantity.", "solution": "The problem requires the derivation and calculation of the \"percent cross-reactivity\" for a competitive binding immunoassay from first principles.\n\nFirst, the problem statement is validated.\n\n**Step 1: Extract Givens**\n-   Binding reactions: $R + A \\rightleftharpoons RA$ and $R + I \\rightleftharpoons RI$.\n-   $R$: free capture antibody.\n-   $A$: true analyte.\n-   $I$: interferent.\n-   $RA$: antibody-analyte complex.\n-   $RI$: antibody-interferent complex.\n-   Association constants: $K_{a,A}$ for reaction with $A$, and $K_{a,I}$ for reaction with $I$.\n-   Affinity ratio: $r = \\frac{K_{a,I}}{K_{a,A}}$.\n-   Numerical value of affinity ratio: $r = 0.1$.\n-   Concentration relationship: $[I] = 10 \\times [A]$.\n-   Assumptions: thermodynamic equilibrium, mass action law, single non-cooperative binding site for both $A$ and $I$.\n-   Signal model: The macroscopic signal $S$ is proportional to the total fraction of occupied capture sites. The detection system does not distinguish between $RA$ and $RI$.\n-   Definition of \"percent cross-reactivity\": \"the ratio of the signal contributed by $I$ to the signal contributed by $A$ under the same $[A]$ and $[I]$ conditions, expressed as a decimal fraction\".\n-   Required precision: Round final numeric answer to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientifically Grounded**: The problem is based on the fundamental principles of chemical equilibrium and mass action, which are cornerstones of biochemistry and analytical chemistry. The competitive binding model is standard for analyzing immunoassays. The premises are factually and scientifically sound.\n-   **Well-Posed**: The problem is well-defined. It provides all necessary constants and relationships to calculate a specific, clearly defined ratio. A unique solution is expected.\n-   **Objective**: The problem is stated in precise, objective, and technical language, free from ambiguity or subjective content.\n-   The problem does not exhibit any flaws such as scientific unsoundness, missing information, internal contradictions, or infeasible conditions. The values provided ($r=0.1$, $[I]=10 \\times [A]$) are entirely plausible for an assay specificity validation experiment.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. A rigorous solution will be derived.\n\n**Solution Derivation**\nThe analysis begins with the law of mass action applied to the two competing binding equilibria at thermodynamic equilibrium.\n\nThe reaction for the analyte $A$ binding to the receptor $R$ is:\n$$R + A \\rightleftharpoons RA$$\nThe association constant, $K_{a,A}$, is defined as:\n$$K_{a,A} = \\frac{[RA]}{[R][A]}$$\nwhere $[RA]$, $[R]$, and $[A]$ are the molar concentrations of the antibody-analyte complex, the free antibody, and the free analyte at equilibrium, respectively.\n\nSimilarly, the reaction for the interferent $I$ binding to the receptor $R$ is:\n$$R + I \\rightleftharpoons RI$$\nThe association constant, $K_{a,I}$, is defined as:\n$$K_{a,I} = \\frac{[RI]}{[R][I]}$$\nwhere $[RI]$ and $[I]$ are the molar concentrations of the antibody-interferent complex and the free interferent at equilibrium.\n\nThe problem states that the signal $S$ is proportional to the fraction of occupied capture sites. Since the detection system does not distinguish between species bound to the receptor, the signal produced by an $RA$ complex is indistinguishable from that produced by an $RI$ complex. The total signal $S_{total}$ is the sum of the signal contributed by the analyte, $S_A$, and the signal contributed by the interferent, $S_I$.\nLet $k$ be the proportionality constant that relates the concentration of a bound complex to the signal it generates. Then:\n$$S_A = k[RA]$$\n$$S_I = k[RI]$$\n\nThe \"percent cross-reactivity,\" which we will denote as $C_R$, is defined as the ratio of the signal contributed by $I$ to the signal contributed by $A$.\n$$C_R = \\frac{S_I}{S_A} = \\frac{k[RI]}{k[RA]}$$\nThe proportionality constant $k$ cancels, yielding an expression purely in terms of equilibrium concentrations:\n$$C_R = \\frac{[RI]}{[RA]}$$\nTo find this ratio, we rearrange the equilibrium constant expressions to solve for $[RA]$ and $[RI]$:\n$$[RA] = K_{a,A} [R] [A]$$\n$$[RI] = K_{a,I} [R] [I]$$\nNow, we can substitute these into the expression for $C_R$:\n$$C_R = \\frac{K_{a,I} [R] [I]}{K_{a,A} [R] [A]}$$\nThe concentration of the free receptor, $[R]$, which is common to both equilibria, cancels from the numerator and denominator. This is a critical result, as it indicates the ratio is independent of the total receptor concentration and the degree of receptor saturation, provided that $[R]  0$.\n$$C_R = \\frac{K_{a,I} [I]}{K_{a,A} [A]}$$\nThis expression can be rearranged to group the affinity constants and the ligand concentrations:\n$$C_R = \\left(\\frac{K_{a,I}}{K_{a,A}}\\right) \\left(\\frac{[I]}{[A]}\\right)$$\nThe problem provides definitions for these two ratios. The affinity ratio is given as $r = \\frac{K_{a,I}}{K_{a,A}}$. The concentration relationship is given as $[I] = 10 \\times [A]$, which implies $\\frac{[I]}{[A]} = 10$.\n\nSubstituting these definitions into the derived expression for $C_R$:\n$$C_R = r \\cdot \\frac{[I]}{[A]}$$\nThis is the general expression for the cross-reactivity ratio under the stated assumptions.\n\nFinally, we compute the numerical value using the provided data:\n-   $r = 0.1$\n-   $\\frac{[I]}{[A]} = 10$\n\n$$C_R = (0.1) \\times (10) = 1.0$$\nThe problem requires the answer to be rounded to four significant figures. The exact value is $1$. Expressed to four significant figures, this is $1.000$. This result indicates that, under the specified conditions, the signal contribution from the interferent is exactly equal to the signal contribution from the true analyte. The interferent's $10$-fold higher concentration perfectly compensates for its $10$-fold lower binding affinity.", "answer": "$$\\boxed{1.000}$$", "id": "4989933"}, {"introduction": "A measurement is only valuable if it is reproducible. For a biomarker assay, total measurement variability arises from multiple sources, such as day-to-day changes, differences between analytical runs, and within-run analytical noise, and quantifying the contribution of each source is essential for establishing the assay's precision. By applying a nested Analysis of Variance (ANOVA) model, this exercise [@problem_id:4989917] illustrates how to decompose total variance into its constituent components, allowing for the calculation of a comprehensive coefficient of variation (CV) that reflects the assay's real-world reproducibility.", "problem": "A clinical laboratory is analytically validating a quantitative immunoassay for a protein biomarker as part of translational medicine readiness. To quantify reproducibility, the laboratory has conducted a balanced nested study with $d=4$ days, $r=3$ analytical runs per day, and $n=5$ replicate measurements per run on a single quality control material at a target level. Let $y_{ijk}$ denote the $k$th replicate measurement from run $j$ on day $i$. The observed grand mean concentration across all measurements is $\\mu=50\\ \\text{ng/mL}$. The Analysis of Variance (ANOVA) summary computed from these data yields the following balanced components: day effect with sum of squares $SS_{\\text{day}}=60$ and degrees of freedom $df_{\\text{day}}=3$, run within day with $SS_{\\text{run(day)}}=40$ and $df_{\\text{run(day)}}=8$, and within-run (residual) with $SS_{\\text{res}}=120$ and $df_{\\text{res}}=48$.\n\nUsing a two-way nested random-effects framework that treats day and run (nested within day) as random effects, do the following in order, starting from core definitions of variance components and expected mean squares for balanced random-effects models and without using any pre-stated shortcut formulas:\n\n1) Write down a hierarchical random-effects model for $y_{ijk}$ that includes a day effect, a run-within-day effect, and a within-run (analytical) error term. Define the between-day variance $\\sigma_{d}^{2}$ and the within-run variance $\\sigma_{w}^{2}$ in this model, and indicate the role of run-within-day variation in the decomposition.\n\n2) From first principles of expected mean squares in balanced nested random-effects ANOVA, derive method-of-moments estimators for $\\sigma_{w}^{2}$ and $\\sigma_{d}^{2}$ in terms of the ANOVA mean squares and the design parameters $d$, $r$, and $n$.\n\n3) Using the provided ANOVA summaries and the design parameters $d=4$, $r=3$, and $n=5$, compute numerical estimates of $\\sigma_{w}^{2}$ and $\\sigma_{d}^{2}$. Then, for a single measurement taken on a randomly chosen day and run, compute the total assay coefficient of variation (CV, coefficient of variation), defined as the ratio of the standard deviation of a single future measurement (which includes all relevant variance components for that measurement) to the grand mean $\\mu$. Express the final coefficient of variation as a decimal (no percent sign), and round your answer to four significant figures. Do not report any intermediate values; provide only the final decimal number.", "solution": "The problem is valid as it is scientifically grounded, well-posed, and objective, with all necessary data provided for a complete solution. The task is to analyze reproducibility data from a nested study using a random-effects model.\n\nThe analysis proceeds in three parts as requested.\n\nPart 1: Hierarchical Random-Effects Model\n\nA two-way nested random-effects model is appropriate for this experimental design. Let $y_{ijk}$ be the concentration measurement for the $k$th replicate ($k=1, ..., n$) of the $j$th run ($j=1, ..., r$) on the $i$th day ($i=1, ..., d$). The model is formulated as:\n$$y_{ijk} = \\mu + D_i + R_{j(i)} + \\epsilon_{ijk}$$\nwhere:\n- $\\mu$ is the true overall mean concentration of the quality control material.\n- $D_i$ is the random effect associated with day $i$. It represents the deviation of the mean of day $i$ from the overall mean $\\mu$. These effects are assumed to be independent and identically distributed (i.i.d.) from a normal distribution with mean $0$ and variance $\\sigma_{d}^{2}$, i.e., $D_i \\sim N(0, \\sigma_{d}^{2})$. The variance component $\\sigma_{d}^{2}$ is the between-day variance, quantifying the variability from one day to another.\n- $R_{j(i)}$ is the random effect of run $j$ nested within day $i$. It represents the deviation of the mean of run $j$ on day $i$ from the mean of day $i$. These effects are assumed to be i.i.d. from a normal distribution with mean $0$ and variance $\\sigma_{r}^{2}$, i.e., $R_{j(i)} \\sim N(0, \\sigma_{r}^{2})$. The variance component $\\sigma_{r}^{2}$ is the between-run, within-day variance. It quantifies the variability that arises from changing analytical runs on the same day.\n- $\\epsilon_{ijk}$ is the random analytical error for the specific measurement $y_{ijk}$. It represents the residual variation, including instrument noise and pipetting variability, that is not accounted for by the day and run effects. These errors are assumed to be i.i.d. from a normal distribution with mean $0$ and variance $\\sigma_{w}^{2}$, i.e., $\\epsilon_{ijk} \\sim N(0, \\sigma_{w}^{2})$. The variance component $\\sigma_{w}^{2}$ is the within-run variance, also called the residual or analytical variance.\n\nThe random terms $D_i$, $R_{j(i)}$, and $\\epsilon_{ijk}$ are assumed to be mutually independent.\n\nPart 2: Derivation of Method-of-Moments Estimators\n\nThe parameters $\\sigma_{w}^{2}$ and $\\sigma_{d}^{2}$ are estimated using the method of moments by equating the observed Analysis of Variance (ANOVA) mean squares to their expected values.\n\nThe mean squares (MS) are calculated from the sums of squares (SS) and degrees of freedom (df):\n- Mean Square for Days: $MS_{\\text{day}} = \\frac{SS_{\\text{day}}}{df_{\\text{day}}}$\n- Mean Square for Runs within Days: $MS_{\\text{run(day)}} = \\frac{SS_{\\text{run(day)}}}{df_{\\text{run(day)}}}$\n- Mean Square for Residuals (within-run): $MS_{\\text{res}} = \\frac{SS_{\\text{res}}}{df_{\\text{res}}}$\n\nFor a balanced nested random-effects model as defined above, the expected mean squares (EMS) are given by:\n1. $E(MS_{\\text{res}}) = \\sigma_{w}^{2}$\n2. $E(MS_{\\text{run(day)}}) = \\sigma_{w}^{2} + n\\sigma_{r}^{2}$\n3. $E(MS_{\\text{day}}) = \\sigma_{w}^{2} + n\\sigma_{r}^{2} + rn\\sigma_{d}^{2}$\n\nTo find the estimators, we replace the expected mean squares with the observed mean squares and the variance components with their estimates ($\\hat{\\sigma}^2$):\nFrom $E(MS_{\\text{res}}) = \\sigma_{w}^{2}$, we directly obtain the estimator for the within-run variance, $\\sigma_{w}^{2}$:\n$$\\hat{\\sigma}_{w}^{2} = MS_{\\text{res}}$$\n\nTo derive the estimator for the between-day variance, $\\sigma_{d}^{2}$, we observe from the EMS equations that $E(MS_{\\text{day}}) = E(MS_{\\text{run(day)}}) + rn\\sigma_{d}^{2}$.\nRearranging for $\\sigma_{d}^{2}$ gives:\n$$\\sigma_{d}^{2} = \\frac{E(MS_{\\text{day}}) - E(MS_{\\text{run(day)}})}{rn}$$\nBy the method of moments, the estimator is:\n$$\\hat{\\sigma}_{d}^{2} = \\frac{MS_{\\text{day}} - MS_{\\text{run(day)}}}{rn}$$\n\nPart 3: Numerical Estimation and Calculation of Total CV\n\nThe given data are:\n- Design parameters: $d=4$ days, $r=3$ runs/day, $n=5$ replicates/run.\n- ANOVA summary: $SS_{\\text{day}}=60$ with $df_{\\text{day}}=3$; $SS_{\\text{run(day)}}=40$ with $df_{\\text{run(day)}}=8$; $SS_{\\text{res}}=120$ with $df_{\\text{res}}=48$.\n- Grand mean: $\\mu = 50\\ \\text{ng/mL}$.\n\nFirst, we compute the mean squares:\n$$MS_{\\text{day}} = \\frac{SS_{\\text{day}}}{df_{\\text{day}}} = \\frac{60}{3} = 20$$\n$$MS_{\\text{run(day)}} = \\frac{SS_{\\text{run(day)}}}{df_{\\text{run(day)}}} = \\frac{40}{8} = 5$$\n$$MS_{\\text{res}} = \\frac{SS_{\\text{res}}}{df_{\\text{res}}} = \\frac{120}{48} = 2.5$$\n\nNext, we use the derived estimators to compute the variance components:\nThe within-run variance estimate is:\n$$\\hat{\\sigma}_{w}^{2} = MS_{\\text{res}} = 2.5$$\nThe between-day variance estimate is:\n$$\\hat{\\sigma}_{d}^{2} = \\frac{MS_{\\text{day}} - MS_{\\text{run(day)}}}{rn} = \\frac{20 - 5}{3 \\times 5} = \\frac{15}{15} = 1$$\nFor completeness, we also estimate the between-run, within-day variance, $\\sigma_{r}^{2}$:\n$$\\hat{\\sigma}_{r}^{2} = \\frac{MS_{\\text{run(day)}} - MS_{\\text{res}}}{n} = \\frac{5 - 2.5}{5} = \\frac{2.5}{5} = 0.5$$\n\nThe total variance, $\\sigma_T^2$, for a single measurement taken on a random day and random run is the sum of all variance components, as the random effects are independent:\n$$\\sigma_{T}^{2} = \\sigma_{d}^{2} + \\sigma_{r}^{2} + \\sigma_{w}^{2}$$\nThe estimate of the total variance is:\n$$\\hat{\\sigma}_{T}^{2} = \\hat{\\sigma}_{d}^{2} + \\hat{\\sigma}_{r}^{2} + \\hat{\\sigma}_{w}^{2} = 1 + 0.5 + 2.5 = 4$$\nThe total standard deviation, $\\sigma_T$, is the square root of the total variance:\n$$\\hat{\\sigma}_{T} = \\sqrt{\\hat{\\sigma}_{T}^{2}} = \\sqrt{4} = 2$$\n\nFinally, the total assay coefficient of variation (CV) is the ratio of the total standard deviation to the grand mean:\n$$CV = \\frac{\\hat{\\sigma}_{T}}{\\mu} = \\frac{2}{50} = 0.04$$\nThe problem requires this result to be expressed as a decimal rounded to four significant figures. The calculated value $0.04$ is exact. To express it with four significant figures, we write it as $0.04000$.", "answer": "$$\\boxed{0.04000}$$", "id": "4989917"}]}